Bipartisan PBM Reforms Mark Progress Toward Lower Drug Costs for Patients
February 3, 2026: Washington, DC – Today, the National Consumers League applauds the passage of the bipartisan Consolidated Appropriations Act of 2026 (CAA), which includes meaningful reforms to hold pharmacy benefit managers (PBMs) accountable and bring greater transparency to the prescription drug marketplace. These reforms are an important step toward ensuring that patients, employers, and plan sponsors benefit from lower drug costs—not entities who profit from opaque pricing practices.







